Log In
Print this Print this

human anti-rabies IgG therapy (KamRAB)

Also known as: KedRAB

  Manage Alerts
Collapse Summary General Information
Company Kamada Ltd.
DescriptionAnti-rabies IgG
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationRabies
Indication DetailsPost-exposure prophylaxis of rabies infection
Regulatory Designation
PartnerKedrion Group S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today